Sherins, R J <br/><br/>
Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol).  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Apr 1971 
 - 522-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jcem-32-4-522  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>17-Ketosteroids--blood<br/>Adult<br/>Androgens--biosynthesis<br/>Androstanes--blood<br/>Antimetabolites--pharmacology<br/>Chorionic Gonadotropin--pharmacology<br/>Clinical Trials as Topic<br/>Clomiphene<br/>Dehydroepiandrosterone--blood<br/>Depression, Chemical<br/>Feedback<br/>Follicle Stimulating Hormone--urine<br/>Gonadotropins, Pituitary--metabolism<br/>Humans<br/>Hypothalamo-Hypophyseal System--physiology<br/>Leydig Cells--drug effects<br/>Luteinizing Hormone--blood<br/>Male<br/>Middle Aged<br/>Oxazoles--pharmacology<br/>Pituitary Function Tests<br/>Pituitary Gland--drug effects<br/>Pregnanes--pharmacology<br/>Testosterone--blood